GL1X · GenesisL1 explorer

MolNFT v1 · #106491 · protein

Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant

4S0V · Human orexin receptor type 2 fusion protein to P. abysii…: “Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant”. X-ray diffraction, 2 ligands (SUV, OLA), 5 pockets (best druggability 0.83).…

PDB
4S0V
Type
protein
Length
478 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human orexin receptor type 2 fusion protein to P. abysii glycogen synthase
UniProt
O43614, Q9V2J8
Ligands
SUV, OLA
Pockets
5 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 67% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHuman orexin receptor type 2 fusion protein to P. abysii glycogen synthaseprotein47867% helix, 9% strandO43614, Q9V2J8

Ligands and binding sites

  • SUV · [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl) phenyl]methanone · ligand · chains A
  • OLA · Oleic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16630.830.8743SUV
21140.540.8324empty
31520.450.7621empty
41280.420.7627empty
5540.310.7612empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 4S0V · Crystal structure of the human OX2 orexin receptor bound to the insomnia drug Suvorexant · the same entry in another collection · chain A against A, TM-score 1.00
  • O43614 · AlphaFold monomer V2.0 prediction for orexin receptor type 2 (O43614) · a predicted model of the same protein · chain A against A, TM-score 0.64

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.